Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-21-046119
Filing Date
2021-11-24
Accepted
2021-11-24 21:07:45
Documents
2
Period of Report
2021-11-11

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1628
2 EX-24 DOCUMENT attachment1.htm EX-24 4454
  Complete submission text file 0000899243-21-046119.txt   7686
Mailing Address 4200 MARATHON BLVD. SUITE 200 AUSTIN TX 78756
Business Address 4200 MARATHON BLVD. SUITE 200 AUSTIN TX 78756 737.255.7194
PLUS THERAPEUTICS, INC. (Issuer) CIK: 0001095981 (see all company filings)

EIN.: 330827593 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 3841 Surgical & Medical Instruments & Apparatus

Mailing Address MOLECULAR INSIGHT PHARMCEUTICALS, INC. 160 SECOND STREET CAMBRIDGE MA 02142
Business Address
LaFrance Norman D. (Reporting) CIK: 0001397768 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-34375 | Film No.: 211448925